Oncology and Hematology Associates of Southwest Virginia — Roanoke, Virginia

Oncology and Hematology Associates of Southwest Virginia is a clinical research site located in Roanoke, Virginia, United States 24014.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Oncology and Hematology Associates of Southwest Virginia has participated in 13 clinical trials with 5 currently active.

Therapeutic areas: Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer AJCC v7, Stage IIIB Uterine Corpus Cancer AJCC v7.

Sponsors: GOG Foundation, Radiation Therapy Oncology Group, NSABP Foundation Inc.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology and Hematology Associates of Southwest Virginia?

Oncology and Hematology Associates of Southwest Virginia has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology and Hematology Associates of Southwest Virginia conducted?

Oncology and Hematology Associates of Southwest Virginia has 13 clinical trials on record, with 5 currently active. Their work covers Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer AJCC v7, Stage IIIB Uterine Corpus Cancer AJCC v7.

Is Oncology and Hematology Associates of Southwest Virginia accredited by Crixeo Health?

Yes — Oncology and Hematology Associates of Southwest Virginia holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Oncology and Hematology Associates of Southwest Virginia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.